Health Voitho Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -527.80%
(FY 2022)
- Ebitda -527.80%
(FY 2022)
- Net Worth -109.51%
(FY 2022)
- Total Assets 403.16%
(FY 2022)
About Health Voitho Technologies
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raktim Chattopadhyay, Sudipta Chattopadhyay, Damodaran Prasanth, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300MH2019PTC324261
- Company No.
324261
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Health Voitho Technologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Damodaran Prasanth  | Director | 19-Apr-2019 | Current |
| Raktim Chattopadhyay | Additional Director | 19-Sep-2024 | Current |
| Sudipta Chattopadhyay | Director | 01-Mar-2021 | Current |
| Venkataktyayani Gorantla | Director | 25-Jun-2021 | Current |
Financial Performance and Corporate Structure Insights of Health Voitho Technologies.
Health Voitho Technologies Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 527.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 109.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Health Voitho Technologies?
In 2022, Health Voitho Technologies had a public holding of 70.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Esperer Onco Nutrition Private LimitedActive 5 years 9 monthsRaktim Chattopadhyay and Sudipta Chattopadhyay are mutual person
Esperer Bio-Research Private LimitedActive 6 years 4 monthsRaktim Chattopadhyay, Sudipta Chattopadhyay and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Health Voitho Technologies?
Unlock and access historical data on people associated with Health Voitho Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Health Voitho Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Health Voitho Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
